Status:
UNKNOWN
Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination
Lead Sponsor:
Beijing Tiantan Hospital
Collaborating Sponsors:
Tianjin Medical University General Hospital
Conditions:
NMO Spectrum Disorder
NMDA-R Encephalitis
Eligibility:
All Genders
18+ years
Brief Summary
Determination of autoantibodies against fragments derived from neurons, glia, and myelin sheath is instrumental in aiding diagnosis, differential diagnosis, as well as determining disease status of ne...
Detailed Description
Participants: The sera of patients with CNS demyelinating autoimmune diseases (NMOSD, MOGAD, AE). Primary aim: 1) Compare the specificity, sensitivity, and clinical correlation between CBA and CBA-TS...
Eligibility Criteria
Inclusion
- The patients with suspected NMOSD, MOGAD and AE will be recruited.
- Male and female patients, ≥ 18 years old.
Exclusion
- Abnormal sera, such as hemolysis or lipemia, which will affect the final interpretation of CBA and CBA-TSA;
- The samples with incomplete clinical data that would affect the disease characterization.
Key Trial Info
Start Date :
June 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT05414890
Start Date
June 30 2022
End Date
June 30 2024
Last Update
June 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100010